Results
26,520 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Taub RebeccaDirector |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $280K 539 sh | Jan 13, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $280K 539 sh | Jan 13, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $814K 1,578 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $758K 1,480 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $561K 1,066 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $480K 913 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Newcomb Matthew SChief Financial Officer |  CHYMChime Financial, Inc.Open-market sale · 10b5-1 plan | SELL | $280K 10.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Stonehocker TimothyChief Technology Officer |  SOUNSOUNDHOUND AI, INC.Open-market sale · 10b5-1 plan | SELL | $356K 29.7K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $355K 681 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 14 | McCarthy Brian K.Pres.,Global Sales & Field Ops |  RBRKRubrik, Inc.Open-market sale · 10b5-1 plan | SELL | $281K 3,933 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 14 | Caldwell Nick V.Chief Product Officer |  PTONPELOTON INTERACTIVE, INC.Open-market sale · 10b5-1 plan | SELL | $176K 25.1K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 14 | Congleton JonDirector, Chief Executive Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $294K 9,119 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 14 | McCarthy Brian K.Pres.,Global Sales & Field Ops | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $289K 4,067 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $149K 280 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $145K 271 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $207K 385 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $177K 332 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $229K 440 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $216K 400 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $110K 200 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $160K 299 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $246K 465 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $136K 256 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $154K 280 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $88K 166 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $79K 148 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $217K 400 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 11 | McCarthy Brian K.Pres.,Global Sales & Field Ops | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $140K 2,000 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 11 | Congleton JonDirector, Chief Executive Officer | MLYSMineralys Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $236K 7,117 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 11 | Baig SaqibChief Accounting Officer | PTONPELOTON INTERACTIVE, INC. Open-market sale · 10b5-1 plan | SELL | $35K 5,000 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $21K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Thygesen Allan C.Director, President and CEO |  DOCUDOCUSIGN, INC.Open-market sale · 10b5-1 plan | SELL | $21K 300 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $48K 89 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $16K 30 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $43K 80 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $43K 80 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner |  TEAMAtlassian CorpOpen-market sale · 10b5-1 plan | SELL | $344K 2,347 sh | Jan 13, 2026 traded Jan 12, 2026 |